Concert Pharma Shares Drop 18% After Public Offering Prices
marketwatch.com
news
2022-06-02 14:01:00

By Chris Wack Concert Pharmaceuticals Inc. shares fell 18% to $4.39, a day after the company priced an underwritten public offering of 10 million common shares at $4.75 a share. The stock closed Wednesday's session down 16%. It hit a 52-week high of $6.88 on Tuesday. Concert said it expects proceeds of $47.5 million from the offering, which is expected to close on or about Monday. The company has granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares at the public offering price, less underwriting discounts and commissions.
